Anthem Biosciences Limited (NSE:ANTHEM)
India · Delayed Price · Currency is INR 939.50
-18.00 (-1.88%)
Nov 12, 2026, 3:29 PM IST
Anthem Biosciences Market Cap
Anthem Biosciences has a market cap or net worth of 529.12 billion as of November 12, 2026. It is the 3,283rd most valuable company in the world and the 197th biggest in India. Its market cap has increased by 38.43% in one year.
Market Cap
529.12B
Enterprise Value
522.49B
Revenue
20.50B
Global Rank
Country Rank
#197 India
PE Ratio
86.83
ChartMarket Cap Chart
Since July 21, 2025, Anthem Biosciences's market cap has increased from 410.17B to 529.12B, an increase of 29.00%. That is a compound annual growth rate of 21.41%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2026 | 528.53B | 44.45% |
| Dec 31, 2025 | 365.89B | -10.80% |
| Jul 21, 2025 | 410.17B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biocon | 604.02B |
| OneSource Specialty Pharma | 185.67B |
| Concord Biotech | 126.27B |
| Blue Jet Healthcare | 102.78B |
| Supriya Lifescience | 51.87B |
| Zota Health Care | 45.26B |
| Dishman Carbogen Amcis | 27.23B |
| Panacea Biotec | 22.05B |